New investment to accelerate pivotal PARADIGM Trial progress, FDA regulatory pathway, upper GI early feasibility studies, and ...

XCath Chief Executive Officer Eduardo Fonseca was formerly an Investment Director in the Crescent Group Investments Team and the Chief Corporate Development Officer of Gulftainer USA. In addition ...

XCath’s chief executive officer, Eduardo Fonseca, gave a presentation titled, "The Future of Endovascular Interventions." The exhibition focused on the process behind endovascular robotic ...

Eduardo Fonseca is a Postwar & Contemporary artist who was born in 1993. Numerous key galleries and museums such as Matèria have featured Eduardo Fonseca's work in the past. Artist's alternative names ...

XCath CEO Eduardo Fonseca Spotlights AI in Endovascular Robotics at SLICE Next Frontiers Conference. Share. Session addressed current and future clinical applications for XCath’s technology.